MedTrace Logo

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

NCT00576238 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2008-10-13

No results posted yet for this study

Summary

Topical steroid creams as well as moisturizing creams are important parts of the treatment strategy of atopic eczema. This study aims to investigate the tolerance of a new strong steroid cream in comparison to an already marketed reference cream with equal amount of active but with different cream vehicle. The second part of the study will investigate the possible preventative property of a moisturizing cream on skin that has been previously cleared from eczema.

Conditions

  • Atopic Eczema

Interventions

DRUG

betamethasone valerate

Topical application according to a fixed schedule for three weeks

DRUG

betamethasone valerate

Topical application according to a fixed schedule for three weeks

DRUG

urea

Topical application twice daily for up to 6 months

Sponsors & Collaborators

  • ACO Hud Nordic AB

    lead INDUSTRY

Principal Investigators

  • Berit Berne, MD · Hudkliniken, Akademiska sjukhuset, Uppsala

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2008-02-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576238 on ClinicalTrials.gov